fda compounding semaglutide enforcement news november 2025 Compounded Semaglutide: Safety & Regulation Guide Compound versions of GLP-1 drugs

The FDA label for Zepbound does not list hormonal interaction as a mechanism

Twenty percent of people taking the 12 mg dose experienced dysesthesia, which is an altered sense of touch, according to Dr

About 18% of participants on the highest dose stopped the medication due to side effects

Efficacy and Daily Routines: The Practical Differences Injections show greater maximum GLP-1 effectiveness for weight loss, but daily tablets offer distinct lifestyle advantages for specific routines

Some patients focus on weight reduction, while others focus on diabetes prevention, cardiovascular health, or improved mobility

How retatrutide works Retatrutide engages three receptors at once